We are live on
!
Find out more
State Street SPDR S&P Biotech ETF
474 hedge funds and large institutions have $6.3B invested in State Street SPDR S&P Biotech ETF in 2019 Q4 according to their latest regulatory filings, with 110 funds opening new positions, 122 increasing their positions, 157 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
214% more first-time investments, than exits
New positions opened: 110 | Existing positions closed: 35
20% more funds holding in top 10
Funds holding in top 10: 10 → 12 (+2)
17% more funds holding
Funds holding: 406 → 474 (+68)
16% more capital invested
Capital invested by funds: $5.44B → $6.3B (+$855M)
7.48% less ownership
Funds ownership: 148.18% → 140.7% (-7.5%)
22% less repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 157
72% less call options, than puts
Call options by funds: $882M | Put options by funds: $3.12B
Holders
474
Holders Change
+68
Holders Change %
+16.75%
% of All Funds
9.34%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.24%
New
110
Increased
122
Reduced
157
Closed
35
Calls
$882M
Puts
$3.12B
Net Calls
-$2.24B
Net Calls Change
-$1.26B
Top Buyers
| 1 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$413M |
| 2 |
Goldman Sachs
New York
|
+$334M |
| 3 |
N
Natixis
Paris,
France
|
+$170M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$111M |
| 5 |
Barclays
London,
United Kingdom
|
+$71.7M |
Top Sellers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$909M |
| 2 |
JP Morgan Chase
New York
|
-$564M |
| 3 |
Citigroup
New York
|
-$168M |
| 4 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
-$75.6M |
| 5 |
DA
Duality Advisers
Miami,
Florida
|
-$67.2M |